锦欣生殖(01951)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01951 锦欣生殖

已收盘 04-27 16:08:30

2.380

-0.090

-3.64%

最高2.480	最低2.380	成交量1,328万
今开2.470	昨收2.470	日振幅4.05%
总市值64.38亿	流通市值64.38亿	总股本27.05亿
成交额3,185万	换手率0.49%	流通股本27.05亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01951","market":"HK","secType":"STK","nameCN":"锦欣生殖","latestPrice":2.38,"timestamp":1777277310002,"preClose":2.47,"halted":0,"volume":13275000,"delay":0,"changeRate":-0.036437246963562875,"floatShares":2705000000,"shares":2705000000,"eps":-0.4134994827424058,"marketStatus":"已收盘","change":-0.09,"latestTime":"04-27 16:08:30","open":2.47,"high":2.48,"low":2.38,"amount":31850997,"amplitude":0.040486,"askPrice":2.39,"askSize":344000,"bidPrice":2.38,"bidSize":195500,"shortable":3,"etf":0,"ttmEps":-0.4134994827424058,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1777339800000},"marketStatusCode":5,"adr":0,"listingDate":1561392000000,"exchange":"SEHK","adjPreClose":2.47,"dividendRate":0.01783,"openAndCloseTimeList":[[1777253400000,1777262400000],[1777266000000,1777276800000]],"volumeRatio":1.032822,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01951","defaultTab":"news","newsList":[{"id":"2629078899","title":"多家机构密集发布研报，看好锦欣生殖2026年业绩复苏","url":"https://stock-news.laohu8.com/highlight/detail?id=2629078899","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629078899?lang=zh_cn&edition=full","pubTime":"2026-04-24 12:17","pubTimestamp":1777004222,"startTime":"0","endTime":"0","summary":"随着年报披露季收官，辅助生殖龙头企业锦欣生殖引发资本市场广泛关注。近日，中金公司、华泰证券、光大证券、华兴证券等多家机构密集发布研报，普遍维持“买入”或“跑赢行业”评级，一致看好该公司在2026年的业绩复苏前景。　　同时，4月21日，锦欣生殖发布了“对股东的一封信”，强调公司目前聚焦中国内地业务，增加股东回报。数据显示，今年以来，锦欣生殖进行了多次股票回购，斥资逾3700万，并注销了前期已回购的超5200万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260424/32171164.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1597","BK1583","BK1219","01951"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196431390","title":"锦欣生殖(01951)2025年业绩转亏 聚焦全球辅助生殖布局与协同","url":"https://stock-news.laohu8.com/highlight/detail?id=1196431390","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196431390?lang=zh_cn&edition=full","pubTime":"2026-04-23 21:05","pubTimestamp":1776949501,"startTime":"0","endTime":"0","summary":"锦欣生殖于2025年度实现收入26.49亿元人民币，同比下降5.8%，经调整净利润2.09亿元人民币较上年减少49.7%，而整体净亏损则达9.84亿元人民币。毛利8.87亿元人民币，同比下降19.3%，毛利率从39.1%收窄至33.5%。报告期内经营活动所得现金净额约5.89亿元人民币，年末银行结余及现金为9.06亿元人民币。同期总资产为139.63亿元人民币，权益总额降至91.99亿元人民币，净利率从2024年的9.7%大幅转负至-37.1%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"锦欣生殖(01951)2025年业绩转亏 聚焦全球辅助生殖布局与协同","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01951"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1199724636","title":"锦欣生殖：4月21日回购约80.30万股，耗资约197.48万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1199724636","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199724636?lang=zh_cn&edition=full","pubTime":"2026-04-21 18:57","pubTimestamp":1776769063,"startTime":"0","endTime":"0","summary":"锦欣生殖医疗集团有限公司于2026年4月21日公告，4月21日公司在香港联交所场内回购股份80.30万股，占当日已发行股本约0.03%。最高回购价每股2.47港元，最低回购价每股2.45港元，合计耗资约197.48万港元。公司同时确认，上述回购行为已遵守香港联交所上市规则及相关法规规定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"锦欣生殖：4月21日回购约80.30万股，耗资约197.48万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01951"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132276231","title":"锦欣生殖4月20日回购322.5万股，耗资约788.61万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1132276231","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132276231?lang=zh_cn&edition=full","pubTime":"2026-04-21 18:47","pubTimestamp":1776768463,"startTime":"0","endTime":"0","summary":"锦欣生殖于2026年4月20日发布公告，披露当日于香港联交所场内回购普通股。该公司回购股份数量为3,225,000股，占公司已发行股本约0.12%，每股回购价介乎2.43港元至2.45港元，总涉资约7,886,092.50港元，折合约788.61万港元。公司此前已于2025年6月26日通过购回授权，可回购股份总数为274,470,604股。公司确认，此次购回行为遵守香港联交所上市规则及相关法规程序，公告由公司董事董阳签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"锦欣生殖4月20日回购322.5万股，耗资约788.61万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01951"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153492467","title":"锦欣生殖4月20日回购322.50万股，耗资约788.61万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1153492467","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153492467?lang=zh_cn&edition=full","pubTime":"2026-04-20 20:42","pubTimestamp":1776688932,"startTime":"0","endTime":"0","summary":"锦欣生殖于2026年4月20日发布公告，披露在香港联交所场内回购股份事宜。公告指出，公司当日回购3,225,000股，约占其已发行股本的0.12%，每股价格介乎2.43港元至2.45港元，涉及总金额约7,886,092.5港元。根据公告，截至2026年4月15日，公司已发行股份总数为2,705,044,043股。公司方面确认，上述回购行为已遵守香港联交所《主板上市规则》及其他相关法规，且此前呈交的说明函件内容并无重大变动。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"锦欣生殖4月20日回购322.50万股，耗资约788.61万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01951"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628723519","title":"锦欣生殖(01951)4月20日斥资788.6万港元回购322.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2628723519","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628723519?lang=zh_cn&edition=full","pubTime":"2026-04-20 20:40","pubTimestamp":1776688820,"startTime":"0","endTime":"0","summary":"智通财经APP讯，锦欣生殖(01951)发布公告，于2026年4月20日斥资788.6万港元回购322.5万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1430893.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1219","01951","BK1597"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169180544","title":"锦欣生殖4月15日回购206.6万股股份，总额约495.55万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1169180544","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169180544?lang=zh_cn&edition=full","pubTime":"2026-04-15 18:38","pubTimestamp":1776249536,"startTime":"0","endTime":"0","summary":"锦欣生殖（股票代码：01951）于2026年4月15日公告回购2,066,000股股份，约占公司已发行股本的0.08%。本次回购价格区间介乎每股2.39港元至2.40港元，合计涉资约495.55万港元。因上述股份尚未注销，公司于回购后已发行股本暂维持2,705,044,043股不变。\n公司表示，本次回购基于2025年6月26日通过的购回授权展开，授权可回购股份总数为274,470,604股。截至目前，已累计回购51,234,000股，约占授权通过当日已发行股本的1.8666%。公司确认本次交易严格遵守香港联交所上市规则及相关法例。\n公告由公司董事董阳签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01951"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627283756","title":"锦欣生殖(01951)4月15日斥资495.55万港元回购206.6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2627283756","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627283756?lang=zh_cn&edition=full","pubTime":"2026-04-15 18:29","pubTimestamp":1776248981,"startTime":"0","endTime":"0","summary":"智通财经APP讯，锦欣生殖(01951)发布公告，于2026年4月15日斥资495.55万港元回购206.6万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1428889.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1597","BK1219","01951","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173016113","title":"锦欣生殖：4月10日回购320万股，耗资约788.90万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1173016113","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173016113?lang=zh_cn&edition=full","pubTime":"2026-04-10 21:51","pubTimestamp":1775829071,"startTime":"0","endTime":"0","summary":"锦欣生殖医疗集团有限公司（01951）于2026年4月10日公告回购3,200,000股普通股，占已发行股本约0.12%。回购价格区间为每股2.44港元至2.47港元，合计支付金额7,888,960港元，约合788.90万港元。\n回购完成后，公司已发行股本仍为2,705,044,043股，库藏股数量为0股。该回购基于2025年6月26日通过的购回授权，公司可回购最多274,470,604股股份，迄今已合计回购49,168,000股。公司确认遵守香港联合交易所有限公司证券上市规则及相关法规。公告由董事董阳签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01951"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626113732","title":"锦欣生殖(01951)4月10日斥资788.9万港元回购320万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2626113732","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626113732?lang=zh_cn&edition=full","pubTime":"2026-04-10 21:41","pubTimestamp":1775828491,"startTime":"0","endTime":"0","summary":"智通财经APP讯，锦欣生殖(01951)发布公告，该公司于2026年4月10日斥资788.9万港元回购320万股股份，每股回购价格为2.44-2.47港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1427337.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1597","BK1219","01951","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118995535","title":"锦欣生殖：4月9日回购3966.2万股，耗资约1.00亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1118995535","media":"公告速递","labels":["shareholding","buyback","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118995535?lang=zh_cn&edition=full","pubTime":"2026-04-09 19:21","pubTimestamp":1775733694,"startTime":"0","endTime":"0","summary":"锦欣生殖医疗集团有限公司（01951）于2026年4月9日发布公告，披露已于2025年12月5日、2025年12月8日至12日、2025年12月15日及2025年12月17日陆续回购部分股份，并于2026年4月9日完成注销。\n本次回购合计3966.2万股，占回购前公司已发行股份的1.45%，每股回购平均价约2.53港元，总耗资约1.00亿港元。完成注销后，已发行股本由2,744,706,043股（另有13,000,000股库藏股）减少至2,705,044,043股，库藏股数为0。\n公司在公告中确认已遵守香港联交所上市规则及相关法律法规。公告由公司董事董阳签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01951"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626189583","title":"锦欣生殖(01951)4月9日注销3966.2万股已回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2626189583","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626189583?lang=zh_cn&edition=full","pubTime":"2026-04-09 19:13","pubTimestamp":1775733203,"startTime":"0","endTime":"0","summary":"智通财经APP讯，锦欣生殖(01951)发布公告，于2026年4月9日注销3966.2万股已回购股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1426674.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","01951","BK1219","BK1597"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192969411","title":"锦欣生殖2026年3月月报：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1192969411","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192969411?lang=zh_cn&edition=full","pubTime":"2026-04-09 17:01","pubTimestamp":1775725319,"startTime":"0","endTime":"0","summary":"锦欣生殖医疗集团有限公司于2026年4月9日发布截至2026年3月31日的股份变动月报表。公告显示，公司本月未有新增发行或注销活动，股本结构保持稳定。已发行股份数目仍为2,744,706,043股，库藏股数目为13,000,000股，合计2,757,706,043股，亦与上月保持一致。公司另行提及，自2025年12月5日至2026年3月31日期间已回购45,968,000股普通股，惟截至本报告期末尚未注销。公司在公告中确认已遵守香港联交所《上市规则》及相关法律规定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01951"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164959860","title":"锦欣生殖：3月31日回购195.50万股，耗资约462.49万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1164959860","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164959860?lang=zh_cn&edition=full","pubTime":"2026-03-31 22:11","pubTimestamp":1774966318,"startTime":"0","endTime":"0","summary":"锦欣生殖(01951)于2026年3月31日发布公告，披露当日于香港联交所场内回购普通股195.50万股，每股回购价介乎2.35港元至2.37港元，涉资约462.49万港元。公司已发行股本及库藏股数量截至当日分别维持在约27.45亿股及1300万股。\n根据公告，公司获准于2025年6月26日通过的购回授权最多可回购约2.74亿股，至今已依据该授权累计购回约4596.80万股，占授权通过当日已发行股份(不含库藏股)的1.6748%。公司确认已遵守香港联交所证券上市规则及相关法例。公告由董事董阳签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01951"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623594306","title":"锦欣生殖（1951.HK）：拐点确立，从修复走向兑现","url":"https://stock-news.laohu8.com/highlight/detail?id=2623594306","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623594306?lang=zh_cn&edition=full","pubTime":"2026-03-31 15:12","pubTimestamp":1774941159,"startTime":"0","endTime":"0","summary":"对于锦欣生殖而言，2025年是修复之年，而2026年，则是其由修复走向兑现，重新定义行业价值标杆的启航之年。","market":"sg","thumbnail":"https://img2.gelonghui.com/b17e2-41d553c2-0d61-48e5-8fc0-0317e77cb1fa.jpg?guru_height=720&guru_width=1280&guru_size=154189","type":0,"news_type":0,"thumbnails":["https://img2.gelonghui.com/b17e2-41d553c2-0d61-48e5-8fc0-0317e77cb1fa.jpg?guru_height=720&guru_width=1280&guru_size=154189"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4251611","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1597","BK1583","BK1219","01951"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623308546","title":"【券商聚焦】华泰证券维持锦欣生殖(01951)“买入”评级 看好新院区与海外业务驱动增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2623308546","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623308546?lang=zh_cn&edition=full","pubTime":"2026-03-31 13:51","pubTimestamp":1774936275,"startTime":"0","endTime":"0","summary":"金吾财讯 | 华泰证券发布研报指，锦欣生殖 的核心投资逻辑在于深圳新院区产能释放与海外业务受益于商保法案执行，将共同驱动公司周期数增长与盈利能力改善，预计2026年收入恢复正增长，经调整净利润较2025年有明显提升。报告指出，锦欣生殖2025年收入为26.49亿元，同比下滑5.8%，经调整净利润为2.09亿元，同比下滑49.7%。维持“买入”评级。","market":"sg","thumbnail":"https://static.szfiu.com/news/20210810/MzhhOTAyYTdjZDRiNjM5MzViNDA1NmM1MGJjYTk1ODE0Mjk0NzY1Nzk3.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/MzhhOTAyYTdjZDRiNjM5MzViNDA1NmM1MGJjYTk1ODE0Mjk0NzY1Nzk3.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1977850","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01951"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623376489","title":"中金：维持锦欣生殖(01951)“跑赢行业”评级 目标价3.50港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2623376489","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623376489?lang=zh_cn&edition=full","pubTime":"2026-03-31 09:41","pubTimestamp":1774921265,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中金发布研报称，维持锦欣生殖26-27年经调整净利润预测2.76/3.57亿元。维持“跑赢行业”评级及目标价3.50港元，目标价对应26-27年31.1/23.7倍P/E，较最新收盘价有50.9%上升空间。中金主要观点如下：2025年业绩符合该行预期公司公布25全年业绩：收入26.49亿元，经调整净利润2.09亿元，符合该行预期。公司正积极推进美国业务重组以回笼资金，计划扩大医师网络至40人，公司预计规模效应将在26年集中体现。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1422714.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["EWH","01951"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623479033","title":"锦欣生殖(01951)3月30日斥资192.98万港元回购83.35万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2623479033","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623479033?lang=zh_cn&edition=full","pubTime":"2026-03-31 00:26","pubTimestamp":1774888009,"startTime":"0","endTime":"0","summary":"智通财经APP讯，锦欣生殖(01951)发布公告，于2026年3月30日斥资192.98万港元回购83.35万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1422399.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01951","BK1583","BK1597","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159521624","title":"锦欣生殖：3月30日回购83.35万股，耗资约192.98万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1159521624","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159521624?lang=zh_cn&edition=full","pubTime":"2026-03-30 22:41","pubTimestamp":1774881710,"startTime":"0","endTime":"0","summary":"锦欣生殖于2026年3月30日公告，公司当日于香港联交所场内回购833,500股普通股，占已发行股本约0.03%，每股回购价介乎2.30港元至2.33港元，合共涉资约192.98万港元。该批回购股份拟注销但尚未注销。回购授权决议于2025年6月26日获通过，授权总数为274,470,604股，公司至今已在香港联交所或其他证券交易所累计回购44,013,000股，占授权通过当日已发行股本约1.6036%。公司确认，本次回购行为符合香港联合交易所有限公司证券上市规则等相关法例的规定。公告由董事董阳签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01951"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113849223","title":"锦欣生殖：3月27日回购约351.75万股，耗资约804.73万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1113849223","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113849223?lang=zh_cn&edition=full","pubTime":"2026-03-30 20:11","pubTimestamp":1774872667,"startTime":"0","endTime":"0","summary":"锦欣生殖（01951）于2026年3月27日披露回购股份事宜。公司当日于香港联交所场内回购约3,517,500股，约占已发行股本0.13%。回购价格介乎每股2.26港元至2.31港元，总金额约8,047,336.50港元。\n根据公告，公司回购授权由股东于2025年6月26日通过，授权总数为274,470,604股。截至该日，公司已累计回购43,179,500股，占购回授权当日公司已发行股本1.5732%。本次回购股份尚未注销，变动后公司已发行股本仍维持在2,744,706,043股，库存股数量为13,000,000股。\n公司表示，回购事宜已遵守上市规则及相关法律法规。公告由董事董阳签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01951"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.jxr-fertility.com","stockEarnings":[{"period":"1week","weight":0.0466},{"period":"1month","weight":0.1176},{"period":"3month","weight":-0.0237},{"period":"6month","weight":-0.0276},{"period":"1year","weight":-0.1902},{"period":"ytd","weight":0.0378}],"compareEarnings":[{"period":"1week","weight":-0.007},{"period":"1month","weight":0.0253},{"period":"3month","weight":-0.0288},{"period":"6month","weight":-0.007},{"period":"1year","weight":0.1857},{"period":"ytd","weight":0.0136}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"锦欣生殖医疗集团有限公司是一家投资控股公司，主要提供试管受精（IVF）服务。该公司通过其子公司主要提供辅助生殖服务、管理服务、流动手术中心设施服务、辅助医疗服务、妇产儿科医疗服务，以及从事医疗消耗品及设备销售业务。该公司主要在中国及美国提供服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.075891},{"month":2,"riseRate":0.714286,"avgChangeRate":0.046911},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.082521},{"month":4,"riseRate":0.571429,"avgChangeRate":0.036528},{"month":5,"riseRate":0.666667,"avgChangeRate":0.054794},{"month":6,"riseRate":0.666667,"avgChangeRate":0.034942},{"month":7,"riseRate":0.428571,"avgChangeRate":-0.041695},{"month":8,"riseRate":0.142857,"avgChangeRate":-0.091907},{"month":9,"riseRate":0.285714,"avgChangeRate":0.03785},{"month":10,"riseRate":0.428571,"avgChangeRate":0.006103},{"month":11,"riseRate":0.285714,"avgChangeRate":0.086782},{"month":12,"riseRate":0.285714,"avgChangeRate":-0.025172}],"exchange":"SEHK","name":"锦欣生殖","nameEN":"JXR"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"锦欣生殖(01951)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供锦欣生殖(01951)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"锦欣生殖,01951,锦欣生殖股票,锦欣生殖股票老虎,锦欣生殖股票老虎国际,锦欣生殖行情,锦欣生殖股票行情,锦欣生殖股价,锦欣生殖股市,锦欣生殖股票价格,锦欣生殖股票交易,锦欣生殖股票购买,锦欣生殖股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"锦欣生殖(01951)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供锦欣生殖(01951)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}